Bladder Urothelial Carcinoma (TCGA, Firehose Legacy)

Summary

Bladder Urothelial Carcinoma (TCGA, Firehose Legacy) is a study catalogued by cBioPortal DataHub under the cancer-type code blca. EvidenceHelix groups it with kidney and bladder studies and lists it in the TCGA Firehose Legacy collection.

Study description

TCGA Bladder Urothelial Carcinoma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/BLCA/20160128/). Previously known as TCGA Provisional.

Text as published in the source's study metadata.

Citation & PubMed

The source lists no citation or PubMed id for this study.

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

blca_tcga

Short name

Bladder (TCGA)

Source cancer-type code

blca

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data. TCGA data are available under the Broad Institute GDAC TCGA Analysis Pipeline License; TCGA-derived records are preliminary or legacy releases.

Citations

The source lists no citation or PubMed id for this study.

Related studies

• Bladder Cancer (MSK, Eur Urol 2014)

  Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder. Targeted sequencing of 109 tumor samples (MSKCC, European Urology 2014).

  Kidney and bladderMSK studiesSource code blcaPubMed 1

• Bladder Cancer (MSK, J Clin Onco 2013)

  Comprehensive profiling of 97 high-grade bladder tumors, including targeted sequencing of 15 cancer genes

  Kidney and bladderMSK studiesSource code blcaPubMed 1

• Bladder Cancer (MSK, Nat Genet 2016)

  Whole exome and targeted sequencing of 34 plasmacytoid-variant (signet ring cell) tumors of the bladder

  Kidney and bladderMSK studiesSource code blcaPubMed 1

• Bladder Cancer (MSK/TCGA, 2020)

  Whole-exome or targeted sequencing of 476 muscle-invasive bladder tumor/normal pairs via TCGA or MSK-IMPACT sequencing.

  Kidney and bladderTCGA (other releases)Source code blcaPubMed 1

• Bladder Cancer (TCGA, Cell 2017)

  Whole-exome sequencing of 412 muscle-invasive bladder tumors and matched normal samples.

  Kidney and bladderTCGA (other releases)Source code blcaPubMed 1

• Bladder Urothelial Carcinoma (BGI, Nat Genet 2013)

  Whole-exome and whole-genome sequencing of 99 bladder cancer tumor/normal pairs. Generated by BGI.

  Kidney and bladderOther published and consortium studiesSource code blcaPubMed 1

• Bladder Urothelial Carcinoma (DFCI/MSK, Cancer Discov 2014)

  Whole exome sequencing of tumor/normal samples from 50 patients treated with cisplatin-based chemotherapy for muscle invasive urothelial carcinoma.

  Kidney and bladderMSK studiesSource code blcaPubMed 1

• Bladder Urothelial Carcinoma (TCGA, Nature 2014)

  Whole-exome sequencing of 131 high-grade muscle-invasive urothelial bladder carcinomas

  Kidney and bladderTCGA (other releases)Source code blcaPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.